ÃÛÌÒÊÓÆµ

ÃÛÌÒÊÓÆµ

  • May 22, 2025

    EpiPen Direct Buyers, Mylan Get Final OK On Antitrust Deal

    Mylan Pharmaceuticals' $73.5 million settlement with a class of direct EpiPen buyers has received final approval from a Kansas federal judge, closing out claims from institutional drug resellers that Mylan worked with Pfizer to forestall an EpiPen generic from hitting the market and artificially inflating prices for the emergency injectable.

  • May 22, 2025

    Rolex Accuses ATL Jewelers Of Knockoff Watch Sales

    Luxury watchmaker Rolex filed a lawsuit Wednesday against two Atlanta jewelry stores, alleging the stores have violated Rolex's trademarks by restoring old second-hand watches with new bling and passing them off as genuine.

  • May 22, 2025

    Isaac Hayes Estate Seeks Clarification In Trump Copyright Suit

    The estate of deceased soul singer and songwriter Isaac Hayes and its related company asked a Georgia federal court on Thursday to clarify or reconsider its order dismissing several claims from their copyright infringement suit against President Donald Trump and his 2024 campaign.

  • May 22, 2025

    Susman Godfrey Partner To Lead News Orgs In OpenAI MDL

    A Susman Godfrey LLP heavy-hitter who helped orchestrate a $787 million settlement in Dominion Voting Systems' defamation suit against Fox News will lead news organizations in their potentially big-dollar copyright claims against Microsoft and OpenAI, a Manhattan federal judge heard Thursday.

  • May 22, 2025

    Beastie Boys Settle 'Sabotage' IP Suit With Chili's Owner

    The Beastie Boys have reached a settlement in their copyright infringement suit in New York federal court against Chili's owner Brinker International Inc., which was accused of using one of the rap group's songs, "Sabotage," in social media marketing without permission.

  • May 21, 2025

    Steve Madden Alleges Adidas Is Trying To Monopolize Stripes

    Steve Madden Ltd. on Wednesday hauled Adidas into New York federal court, saying it was "tired" of being targeted by the athletic apparel and footwear company for using elements it says bear no resemblance to the three parallel stripes donning Adidas products.

  • May 21, 2025

    Squires Talks Fortress, PTAB Invalidations In Senate Hearing

    The Trump administration's nominee for U.S. Patent and Trademark Office director had his moment before the Senate Judiciary Committee on Wednesday, where he downplayed his controversial connections to litigation finance giant Fortress Investment Group and raised concerns that too many bad patents were being issued.

  • May 21, 2025

    9th Circ. Judge Asks If Apple's Watch Updates 'Ice Out' Rivals

    Two Ninth Circuit judges appeared skeptical Wednesday of Apple Inc.'s arguments against reviving an antitrust suit brought by medical monitoring startup AliveCor Inc. after Apple blocked third-party access to medical data on the Apple Watch, with one judge asking rhetorically whether a "marginal" improvement by Apple could actually be a way to "ice out" competition.

  • May 21, 2025

    Tesla Cites Nat'l Security In Bid To Keep PTAB Challenge Alive

    Tesla Inc. has argued that "national security interests" support its Patent Trial and Appeal Board challenge to a digital camera patent that it's accused of infringing, urging the U.S. Patent and Trademark Office's acting director to reject the patent owner's bid to toss the challenge under new board procedures.

  • May 21, 2025

    Albright Sends Patent Suit Against Amazon To Calif.

    A Texas federal judge transferred a software company's patent infringement suit against Amazon and two affiliates to California federal court on Wednesday.

  • May 21, 2025

    ITC To Eye Qualcomm, Nvidia Circuit Imports Over Onesta IP

    The U.S. International Trade Commission will look into allegations over whether Qualcomm Inc., Nvidia Corp. and others are infringing several electronics patents by importing integrated circuits and electronics devices.

  • May 21, 2025

    GOP FTC Renews Calls For Orange Book Patent Delistings

    The now-Republican controlled Federal Trade Commission again called on Teva, Novartis, Mylan and other drugmakers to remove patents from a key federal database that partially insulates their drugs from generic competition, arguing Wednesday the patents cover "devices," not drugs, and thus don't warrant such protection.

  • May 21, 2025

    DraftKings Denied 3rd Circ. Review In MLB Players' IP Case

    A Pennsylvania judge on Wednesday denied a request from DraftKings Inc. to appeal to the Third Circuit the lower court's refusal to dismiss an intellectual property lawsuit that accuses the company of using players' images without permission, saying the issues raised are not appropriate for immediate appeal.

  • May 21, 2025

    ITC Wants Full Fed. Circ. To Rehear Lashify Dispute

    The U.S. International Trade Commission wants the Federal Circuit to rethink its finding that the commission was wrongly prohibiting domestic expenses related to sales, marketing and other activities from allowing companies to pursue ITC patent cases.

  • May 21, 2025

    Country Music Singer Urges Sens. To Pass AI Deepfakes Bill

    Country music star Martina McBride urged U.S. senators Wednesday to pass legislation aimed at protecting individuals from having their voice and likeness replicated with artificial intelligence without their permission, saying "it's frightening, and it's wrong."

  • May 21, 2025

    USPTO Tackling Backlog Despite Hiring Freeze, Official Says

    While the U.S. Patent and Trademark Office waits out a federal hiring freeze preventing it from bringing in more patent examiners, it's using initiatives like reassignments and rewards to "do more with less" and cut down on patent pendency, the agency's deputy commissioner for patents said Wednesday.

  • May 21, 2025

    What To Know Before VLSI, Intel's Patent License Trial

    Over the last several years, VLSI Technologies has racked up infringement awards in an expansive multibillion-dollar fight against Intel, but those could be rendered moot after a trial next week, when a Texas federal jury reviews a question central to determining whether Intel already has a license to VLSI's patents.

  • May 21, 2025

    Dem Rep. Calls For Withdrawal Of New PTAB Denial Policies

    A Democratic member of the U.S. House of Representatives representing Silicon Valley told the acting head of the U.S. Patent and Trademark Office that she had "serious concern" regarding new policy in which the director has the final word on whether patent challenges should be denied for discretionary reasons.

  • May 21, 2025

    Innoscience Rips Bid To Undo PTAB Win In Chip IP Fight

    Chinese company Innoscience has urged the acting head of the U.S. Patent and Trademark Office to shut down a California-based semiconductor company's bid to throw out a Patent Trial and Appeal Board decision invalidating one of its patents.

  • May 21, 2025

    Full Fed. Circ. Undoes $20M Google Loss, Orders New Trial

    The full Federal Circuit on Wednesday ordered a new damages trial in a case where a jury told Google LLC to pay $20 million for infringing an EcoFactor Inc. thermostat patent, ruling that the testimony of EcoFactor's damages expert was unreliable and should not have been admitted.

  • May 21, 2025

    Distiller Says Ex-Partner, Attys Used RICO Suit To Ruin Him

    A Pennsylvania distiller claims his erstwhile partner in Pittsburgh's Kingfly Spirits launched years of litigation against him designed to ruin his reputation and career, saying in a complaint of his own that the ex-collaborator texted him "game on" before beginning his abusive legal campaign.

  • May 21, 2025

    Apologetic NJ Atty Gets 21 Months For $350K COVID Fraud

    A New Jersey attorney sentenced to 21 months in federal prison on Wednesday for claiming he was a business in order to receive nearly $350,000 earmarked for small businesses amid the COVID-19 pandemic apologized to the court for the "embarrassment" he caused to the legal profession.

  • May 21, 2025

    Tech Co. Dynavision Says Rival Ripped Off 'Neuro-Visual' IP

    An Ohio-based technology company has brought a lawsuit in federal court claiming the trade dress of its "neuro-visual" training system, used by athletes and others, was ripped off by a rival.

  • May 21, 2025

    Fed. Circ. Rules 'Vetements' Generic, Bars Clothing TM

    The Federal Circuit affirmed the denial of trademark registrations for "Vetements" for clothes, saying in a precedential opinion Wednesday that because the word means clothing in French, the applied-for marks are generic and therefore can't be registered.

  • May 20, 2025

    LG Gets PTAB To Trim Smart TV Patent Claims As Trial Starts

    The Patent Trial and Appeal Board on Monday invalidated claims in two Multimedia Technologies Pte. Ltd. smart television patents that are at issue in an infringement trial against LG in Texas federal court that began the same day.

Expert Analysis

  • Series

    Teaching Business Law Makes Me A Better Lawyer

    Author Photo

    Teaching business law to college students has rekindled my sense of purpose as a lawyer — I am more mindful of the importance of the rule of law and the benefits of our common law system, which helps me maintain a clearer perspective on work, says David Feldman at Feldman Legal Advisors.

  • Series

    Law School's Missed Lessons: Mastering Discovery

    Author Photo

    The discovery process and the rules that govern it are often absent from law school curricula, but developing a solid grasp of the particulars can give any new attorney a leg up in their practice, says Jordan Davies at Knowles Gallant.

  • Patent Takeaways In Fed. Circ.'s 1st Machine Learning Ruling

    Author Photo

    The Federal Circuit’s recent decision in Recentive Analytics v. Fox, a case of first impression affirming the invalidity of patents that applied general machine learning methods to conventional tasks, serves as a cautionary guide for patent practitioners navigating the complexities of machine learning inventions, say attorneys at Foley & Lardner.

  • Opinion

    UK Court Of Appeal's FRAND Ruling Is Troubling

    Author Photo

    The U.K. Court of Appeal's recent decision in Optis v. Apple disregards a lower court's extensive factual findings and contradicts its own precedent regarding fair, reasonable and nondiscriminatory terms for cellular patents, says Enrico Bonadio at the University of London.

  • Opinion

    Int'l Athletes' Wages Should Be On-Campus Employment

    Author Photo

    The U.S. Department of Homeland Security should recognize participation in college athletics by international student-athletes as on-campus employment to prevent the potentially disastrous ripple effects on teams, schools and their surrounding communities, says Catherine Haight at Haight Law Group.

  • Series

    Playing Guitar Makes Me A Better Lawyer

    Author Photo

    Being a lawyer not only requires logic and hard work, but also belief, emotion, situational awareness and lots of natural energy — playing guitar enhances all of these qualities, increasing my capacity to do my best work, says Kosta Stojilkovic at Wilkinson Stekloff.

  • Adapting To PTAB's Reembracing Of Discretionary Denials

    Author Photo

    Recent guidance from the U.S. Patent and Trademark Office marks a swing back toward procedural discretion in Patent Trial and Appeal Board trial institution decisions, bringing unpredictability but also opportunities for drafting petitions, and making and responding to discretionary denial arguments, says Taylor Stemler at Merchant & Gould.

  • Crisis Management Lessons From The Parenting Playbook

    Author Photo

    The parenting skills we use to help our kids through challenges — like rehearsing for stressful situations, modeling confidence and taking time to reset our emotions — can also teach us the fundamentals of leading clients through a corporate crisis, say Deborah Solmor at the Wisconsin Alumni Research Foundation and Cara Peterman at Alston & Bird.

  • 4 Ways To Leverage A Jury's Underdog Perceptions

    Author Photo

    Counsel should consider how common factors that speak to their client's size, power, past challenges and alignment with jurors can be presented to try and paint their client as a sympathetic underdog, says Ken Broda-Bahm at Persuasion Strategies.

  • 4 Legislative Proposals Reflect Growing Scrutiny Of Pharma IP

    Author Photo

    Bipartisan legislative momentum in Congress, including a recent package of bills targeting exclusivity strategies that delay generic and biosimilar competition, signals growing scrutiny of life sciences intellectual property strategies, so biologics companies and investors must pay attention to new strategic, compliance and litigation risks, says Olga Berson at Thompson Coburn.

  • Why Hiring Former Jurors As Consultants Can Be Risky

    Author Photo

    The defense team's decision to hire former juror Victoria George in the high-profile retrial of Karen Read shines a spotlight on this controversial strategy, which raises important legal, ethical and tactical questions despite not being explicitly prohibited, says Nikoleta Despodova at ND Litigation.

  • Series

    Adapting To Private Practice: From NY Fed To BigLaw

    Author Photo

    While the move to private practice brings a learning curve, it also brings chances to learn new skills and grow your network, requiring a clear understanding of how your skills can complement and contribute to a firm's existing practice, and where you can add new value, says Meghann Donahue at Covington.

  • What Businesses Need To Know About EU Design Law Reform

    Author Photo

    Recent reforms to European Union design protection law will broaden the scope of what constitutes protected designs and products, likely creating new opportunities and considerations for businesses operating within the EU or those engaging with its markets, say lawyers at Foley & Lardner.

  • Berry Ruling Shows Why Plant IP Suits Can Be Thorny

    Author Photo

    A California federal court's recent decision in Driscoll's v. California Berry Cultivars illustrates that while a path exists for asserting U.S. plant patent rights against extraterritorial breeders, it can be difficult to prove infringement based on importation of plant parts, say Travis Bliss and Stephany Small at Panitch Schwarze.

  • 7 Considerations For Conducting Drug Clinical Trials Abroad

    Author Photo

    With continuing cuts to U.S. Food and Drug Administration staffing motivating some pharmaceutical companies to consider developing drugs abroad, it's important to understand the additional risks and compliance requirements associated with conducting clinical studies in other countries, say attorneys at Morgan Lewis.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the ÃÛÌÒÊÓÆµ archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!